Metsera, Inc. (NASDAQ:MTSR – Get Free Report)’s share price hit a new 52-week high during trading on Monday . The company traded as high as $31.64 and last traded at $30.19, with a volume of 5601 shares changing hands. The stock had previously closed at $29.50.
Metsera Trading Up 2.3 %
About Metsera
Metsera, Inc is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.
Featured Articles
- Five stocks we like better than Metsera
- Stock Dividend Cuts Happen Are You Ready?
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- Comparing and Trading High PE Ratio Stocks
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- High Dividend REITs: Are They an Ideal Way to Diversify?
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Metsera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metsera and related companies with MarketBeat.com's FREE daily email newsletter.
